NEW YORK – Anbio Biotechnology filed this week a preliminary prospectus for an initial public offering on the Nasdaq exchange of 1.6 million shares at an anticipated offering price in the range of $5 ...

NEW YORK – Anbio Biotechnology filed this week a preliminary prospectus for an initial public offering on the Nasdaq exchange of 1.6 million shares at an anticipated offering price in the range of $5 ...

Anbio Biotechnology seeks IPO funding to expand in the IVD market. Discover why NNNN stock’s potential is tempered by ...

Anbio Biotechnology (NNNN), a developer of in vitro diagnostics, has filed to raise around $9M through a U.S. initial public offering. Read more here.

Anbio Biotechnology filed for a 1.6 million-share initial public offering with the Securities and Exchange Commission. The company said Tuesday it expects the IPO to price between $5 and $6 per share, ...

These efforts place India at the forefront of the global bioplastics movement, showing the world how biotechnology can contribute to a cleaner, more sustainable future,” Singh said, in October.

GangaGen Biotechnologies receives CARB-X funding to develop Klebicins, a novel protein antibiotic targeting multidrug-resistant Klebsiella pneumoniae lung infections. This addresses a critical ...

Nuritas founder and chief executive Nora Khaldi: “Whether you eat it or put it on your skin, our goal is to be in literally every product imaginable.” ...

BOSTON, Dec. 19, 2024 /PRNewswire/ -- Boston Institute of Biotechnology, LLC (BIB), along with its sister company BiBo Pharma, pioneering Contract Development and Manufacturing Organizations ...

York-based Cizzle Biotechnology has announced a deal with a US company to supply its cancer test kits to the Caribbean. The technology works by detecting a specific variant of the CIZ1 protein ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, my colleagues were diligently roaming the halls of ...

Dec 18 (Reuters) - Merck (MRK.N), opens new tab has signed a licensing deal worth up to $2 billion for Chinese biotech Hansoh Pharma's (3692.HK), opens new tab experimental oral drug to treat ...